Profile
James W.
Young served as Non-Executive Chairman at Sunesis Pharmaceuticals, Inc. from 2009 to 2021.
Prior to that, he was a Director at Corixa Corp., Conforma Therapeutics Corp., Chrono Therapeutics, Inc., Impel Pharmaceuticals, Inc., Incline Therapeutics, Inc., Portal Instruments, Inc., and Pearl Therapeutics, Inc. He also served as Senior Vice President-Research & Development at ALZA Corp.
from 1995 to 2000, Senior Vice President-Business Development at Sumitomo Pharma America, Inc. from 1987 to 1992, and President-Pharmaceuticals Division at Affymax NV from 1992 to 1995.
He is currently a Venture Partner Emeritus at 5AM Venture Management LLC and previously worked as a Principal at Zoecon Corp.
Dr. Young received his undergraduate degree from Fordham University and his doctorate from Cornell University.
Former positions of James W. Young
| Companies | Position | End |
|---|---|---|
| VIRACTA THERAPEUTICS, INC. | Chairman | 24/02/2021 |
| ALZA CORPORATION | Chief Tech/Sci/R&D Officer | 01/03/2000 |
Affymax NV
Affymax NV Pharmaceuticals: MajorHealth Technology Operates as a drug discovery company | Corporate Officer/Principal | 01/08/1995 |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Corporate Officer/Principal | 01/08/1992 |
5AM Venture Management LLC
5AM Venture Management LLC Investment ManagersFinance 5AM Ventures invests in companies located in the US with an investment size ranging from $20 to $30 million. The firm targets companies operating in the fields of life sciences. It provides financing for early stage and corporate spin-out capital requirements and also makes co-investments. | Private Equity Investor | - |
Training of James W. Young
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 15 |
|---|---|
ALZA Corp.
ALZA Corp. Pharmaceuticals: MajorHealth Technology Provides and develops pharmaceutical products | Health Technology |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Health Technology |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Develops and manufactures oncology and immunology products | Health Technology |
Sunesis Pharmaceuticals, Inc.
Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology therapeutics for treatment of solid and hematologic cancers | Health Technology |
Conforma Therapeutics Corp.
Conforma Therapeutics Corp. BiotechnologyHealth Technology Designs and develops drugs for treatment of cancer | Health Technology |
Chrono Therapeutics, Inc.
Chrono Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Produces transdermal drug products | Commercial Services |
Impel Pharmaceuticals, Inc.
Impel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a late-stage biopharmaceutical company focused on developing transformative therapies for central nervous system disorders | Health Technology |
Incline Therapeutics, Inc.
Incline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Portal Instruments, Inc.
Portal Instruments, Inc. Medical SpecialtiesHealth Technology Operates as a medical device company that focuses on drug delivery systems | Health Technology |
Affymax NV
Affymax NV Pharmaceuticals: MajorHealth Technology Operates as a drug discovery company | Health Technology |
Fordham University
Fordham University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
5AM Venture Management LLC
5AM Venture Management LLC Investment ManagersFinance 5AM Ventures invests in companies located in the US with an investment size ranging from $20 to $30 million. The firm targets companies operating in the fields of life sciences. It provides financing for early stage and corporate spin-out capital requirements and also makes co-investments. | Finance |
Pearl Therapeutics, Inc.
Pearl Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for the treatment of chronic respiratory diseases | Health Technology |
Zoecon Corp. |
- Stock Market
- Insiders
- James W. Young
















